Next Science Statistics
Total Valuation
Next Science has a market cap or net worth of 18.07 million. The enterprise value is 18.91 million.
| Market Cap | 18.07M |
| Enterprise Value | 18.91M |
Important Dates
The last earnings date was Tuesday, April 22, 2025.
| Earnings Date | Apr 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 292.16M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +24.69% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 139.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.79 |
| PB Ratio | 5.25 |
| P/TBV Ratio | 6.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.79 |
| EV / Sales | 0.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.36 |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.88 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.31 |
| Interest Coverage | -47.28 |
Financial Efficiency
Return on equity (ROE) is -130.18% and return on invested capital (ROIC) is -64.79%.
| Return on Equity (ROE) | -130.18% |
| Return on Assets (ROA) | -47.12% |
| Return on Invested Capital (ROIC) | -64.79% |
| Return on Capital Employed (ROCE) | -170.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.68 |
| Inventory Turnover | 6.04 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.42% in the last 52 weeks. The beta is 1.31, so Next Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -74.42% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.10 |
| Relative Strength Index (RSI) | 55.36 |
| Average Volume (20 Days) | 6,695 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Next Science had revenue of 22.82 million and -10.59 million in losses. Loss per share was -0.04.
| Revenue | 22.82M |
| Gross Profit | 18.44M |
| Operating Income | -10.22M |
| Pretax Income | -10.59M |
| Net Income | -10.59M |
| EBITDA | -9.74M |
| EBIT | -10.22M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 1.67 million in cash and 2.49 million in debt, giving a net cash position of -819,247.
| Cash & Cash Equivalents | 1.67M |
| Total Debt | 2.49M |
| Net Cash | -819,247 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.44M |
| Book Value Per Share | 0.01 |
| Working Capital | 2.83M |
Cash Flow
In the last 12 months, operating cash flow was -7.96 million and capital expenditures -46,320, giving a free cash flow of -8.01 million.
| Operating Cash Flow | -7.96M |
| Capital Expenditures | -46,320 |
| Free Cash Flow | -8.01M |
| FCF Per Share | n/a |
Margins
Gross margin is 80.83%, with operating and profit margins of -44.80% and -46.40%.
| Gross Margin | 80.83% |
| Operating Margin | -44.80% |
| Pretax Margin | -46.40% |
| Profit Margin | -46.40% |
| EBITDA Margin | -42.70% |
| EBIT Margin | -44.80% |
| FCF Margin | n/a |
Dividends & Yields
Next Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.69% |
| Shareholder Yield | -24.69% |
| Earnings Yield | -58.60% |
| FCF Yield | -44.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Next Science has an Altman Z-Score of -9.15. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.15 |
| Piotroski F-Score | n/a |